Clinical trial
Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis
NCT00112008 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00112008 |
|---|---|
| Title | Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis |
| Official title | A Multi-Center, Single-Arm Study Evaluating De Novo Once Every Two Week Darbepoetin Alfa Dosing in Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Kidney Disease |
| Intervention type | Drug |
| Interventions | De Novo Administration of Darbepoetin Alfa |
| Enrollment | 100 |
| Start date | May 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | May 30, 2005 |
| Last update posted | Jul 10, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: